Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kcyB (NF-kcyB) and Extracellular Signal-regulated kinase 1 and 2 (ERK1/2) and Mitogen Stress activated kinase 1 (MSK1) signaling.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
The Fourth International Conference on Regulatory T Cells and TH Subsets and Clinical Applications in Human Disease
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Mechanism of action of mitoxantrone.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Demyelination and Remyelination: From Mechanism to Therapy
Episode 19 with Dr. Samuel Ludwin on treating MS subtypes
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
“Veterinary Medicines” page
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Episode 8 with Dr. Wendy Macklin on myelination and the zebrafish model of MS
The quality of reports of randomized trials in multiple sclerosis: a review.

Pages